Catalyst Wire Dossier Catalyst Wire Dossier

Paliperidone palmitate (long-acting)

paliperidone palmitate · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Paliperidone palmitate (long-acting), covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With Schizophrenia [NA]

See pricing